FourThought Financial’s Boston Scientific BSX Stock Holding History

FourThought Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$140K	Buy	3,604 +1,041	+41%	+$41.8K	0.02%	364
2022 Q2	$96K	Sell	2,563 -296	-10%	-$12K	0.01%	445
2022 Q1	$117K	Buy	2,859 +93	+3%	+$4.03K	0.01%	437
2021 Q4	$117K	Sell	2,766 -129	-4%	-$5.42K	0.01%	443
2021 Q3	$125K	Sell	2,895 -206	-7%	-$9.11K	0.02%	432
2021 Q2	$132K	Sell	3,101 -61	-2%	-$2.57K	0.02%	433
2021 Q1	$122K	Hold	3,162	–	–	0.02%	449
2020 Q4	$113K	Buy	+3,162	New	+$114K	0.02%	456

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

FourThought Financial's BSX Position: Q3 2022 in Review

FourThought Financial increased its Boston Scientific (BSX) stake by 41% in Q3 2022, buying an estimated $41.8K and bringing the position to 3,604 shares worth $140K. The position accounts for 0.02% of the portfolio, ranked #364.

FourThought Financial first reported a position in BSX in Q4 2020 and has held it in 8 quarters since. 865 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

FourThought Financial held 3,604 shares of Boston Scientific worth $140K as of Q3 2022.
FourThought Financial bought 1,041 Boston Scientific shares in Q3 2022, an estimated $41.8K.
Boston Scientific made up 0.02% of FourThought Financial's portfolio in Q3 2022, its #364 holding.
FourThought Financial first reported a position in Boston Scientific in Q4 2020 and has held it in 8 quarters since.
865 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.